Panbela Therapeutics Inc. (PBLA) vs XORTX Therapeutics Inc. (XRTX)

Panbela Therapeutics Inc. and XORTX Therapeutics Inc. are both Biotechnology companies. Panbela Therapeutics Inc. and XORTX Therapeutics Inc. are of similar size ($3.4M and $3.2M). Across the 9 metrics below, Panbela Therapeutics Inc. leads on 5 and XORTX Therapeutics Inc. on 4.

Valuation

Metric PBLA XRTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 0.50 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (711,300.00%) (161.54%) (28.84%)
Free cash flow yield (29,656.02%) (193.17%) (23.03%)

Profitability

Metric PBLA XRTX Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 270.37% (99.24%) (57.72%)
Return on assets (353.47%) (83.78%) (49.22%)
Return on invested capital 0.00% (54.27%) 0.00%

Growth

Metric PBLA XRTX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 99.43% 51.30% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PBLA XRTX Biotechnology median
Debt to equity (0.23) 0.00 0.00
Current ratio 0.26 3.59 4.73
Net debt to EBITDA (0.10) 0.28 0.96

Dividend

Metric PBLA XRTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric PBLA XRTX Biotechnology median
Market cap 3.35m 3.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack